2021 annual financial data
NeuroSense Therapeutics 2021 Net income growth
Direct answer
Net income growth was -42.89%.
Operating income was -5,587,000 USD and net income was -4,041,000 USD.
Operating cash flow was -1,539,000 USD.
Get free NeuroSense Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -5,587,000 USD
- Net income
- -4,041,000 USD
- Operating cash flow
- -1,539,000 USD